30 filings
6-K
IPCIF
Intellipharmaceutics International Inc.
5 Dec 19
Primary Document
9:36am
6-K
IPCIF
Intellipharmaceutics International Inc.
25 Nov 19
Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER
4:39pm
6-K
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing
4:38pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Nov 19
Intellipharmaceutics Announces Settlement Agreement in Class Action Lawsuit, Which is Subject to Court Approval
4:20pm
6-K
IPCIF
Intellipharmaceutics International Inc.
24 Oct 19
Intellipharmaceutics Update on its Oxycodone ER New Drug Application
1:48pm
6-K
xlcf6ej4zl1jmvlsbd
11 Oct 19
Primary Document
5:20pm
6-K
wk6inf2gr9
4 Oct 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
8:07am
6-K
axqfsj2fe
5 Sep 19
Primary Document
1:44pm
6-K
txsm7vme4tj3
15 Aug 19
Primary Document
3:28pm
6-K
qe7 8owfwqvyyu7ei
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
lwilu1 grn82x42
10 Jul 19
Primary Document
5:08pm
6-K
8fn0emy8 6x9pi
8 Jul 19
Primary Document
5:18pm
6-K
82x8y7bnnicdimmy61s
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
2a28f5m91s
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
6-K
67utwb3upkmd8lq7sb
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
3xa9qhkgy2krhtazfxhk
28 May 19
Annual & Special Meeting of Shareholders
4:41pm
6-K
x4k2iff0u9ow63li al
10 May 19
Primary Document
1:07pm
6-K
8tokx3wm
8 May 19
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing
12:00am
6-K
tcnpom1pwpfge 1sm
26 Apr 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
12:00am
6-K
50z isxlbvmyn
15 Apr 19
Primary Document
4:25pm